WHO Recommends Molnupiravir for Non-Severe COVID-19: Treatment Guidelines
The WHO recommends molnupiravir for non-severe COVID-19 patients at increased risk of hospital admission, offering a promising antiviral treatment option to reduce disease progression and prevent severe outcomes in high-risk individuals.
October 2022
US Cancer Screening Shortfalls Amid the Pandemic: Urgent Need for Action
Drops in colorectal cancer screening rates during the COVID-19 pandemic require urgent attention to mitigate delays in cancer detection and ensure timely access to preventive services, underscoring the importance of targeted interventions to address healthcare disparities.
October 2022
Post-COVID-19 Diabetes: Emerging Trends in New Cases
Adults who recover from mild COVID-19 infection face a significantly increased risk of developing type 2 diabetes, underscoring the long-term metabolic consequences of SARS-CoV-2 infection and the need for proactive monitoring and management of post-COVID-19 metabolic disorders.
October 2022
Oral Nirmatrelvir for COVID-19: Therapeutic Potential in High-Risk Adults
Oral nirmatrelvir may slow the progression to severe COVID-19 and rapidly reduce SARS-CoV-2 viral load in high-risk adults, offering a promising antiviral treatment option to mitigate disease severity and prevent hospitalization in vulnerable patient populations.
October 2022
COVID-19 in Athletes: Recommendations for Safe Return to Sports
Athletes recovering from COVID-19 are advised to define the full recovery period before resuming athletic activity to prevent potential cardiac complications and ensure safe participation in sports, emphasizing the importance of individualized management strategies in athlete care.
October 2022
Association Between Acute Kidney Injury and Long-Term Kidney Function After COVID-19
A cohort study with nearly one year of follow-up among COVID-19 patients discharged from the hospital examines the association between acute kidney injury during hospitalization and long-term kidney function outcomes, providing insights into the renal sequelae of SARS-CoV-2 infection.
October 2022
Post-COVID Health Complications in Older Adults: Implications for Healthcare Planning
One in three older adults develops new post-COVID conditions, underscoring the need for anticipatory healthcare planning and resource allocation to address the long-term health consequences of COVID-19 and support the recovery of affected individuals.
October 2022
FDA Fully Approves Moderna COVID-19 Vaccine: Name Change and Regulatory Status
The FDA grants full approval to the Moderna COVID-19 vaccine, allowing it to be marketed under the name Spikevax, reflecting its transition from emergency authorization to full regulatory approval based on safety and efficacy data.
October 2022
High Rapid Antigen Test Positivity Rates After Isolation for COVID-19: Implications for Testing Strategies
Many rapid antigen tests remain positive after 5 days of isolation for COVID-19, leading to high test positivity rates and complicating testing strategies for individuals seeking clearance to end isolation, highlighting the need for careful interpretation of test results and consideration of alternative testing modalities.
October 2022
Cancer Detection Shortfalls During the Pandemic: Urgent Call for Action
Drops in colorectal cancer screening rates during the COVID-19 pandemic require urgent attention to mitigate delays in cancer detection and ensure timely access to preventive services, emphasizing the need for coordinated efforts to address healthcare disruptions.
October 2022
